$LMB

Limbach Holdings (LMB) director buys stock around $49–$51

Limbach Holdings (LMB) director Joshua Horowitz and an affiliated fund bought 7,820 shares in open-market transactions at prices between $48.88 and $51.25 per share on September 11 and 15, 2026. The purchases were made directly and indirectly through Palm Global Small Cap Master Fund LP.

Original reporting
Published Sep 15, 2026, 11:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 7:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$LMB
Neutral
low confidence
Mentioned
$LMB
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$LMBNeutralLow
01

Why it matters

The disclosed purchases are modest and unlikely to shift market perception significantly.

02

Market read

Primary insider purchase filing with limited trading relevance.

03

What to watch

Potential upcoming financing or strategic partnership not disclosed.

Relevance 4/10Novelty 4/10Timing: today

Background

SEC Form 4 filing reports insider transactions for Limbach Holdings.

Company-level read

Ticker impact

$LMBNeutralLow confidence
Context

Form 4 disclosed director Joshua Horowitz and affiliated fund purchased 7,820 shares at $48.88‑$51.25.

Expected impact

Minimal, likely no immediate price movement.

Evidence & confidence

Purchase size (~$400k) is modest for a micro‑cap; typical insider buys have low short‑term effect.

Market effects

None; transaction is company‑specific.

None; limited to the micro‑cap's niche market.

None

Counterpoint

Insider purchase could be a pre‑emptive move before a negative catalyst.

Key entities

  • Joshua Horowitz

    Limbach Holdings director and purchaser.

  • Palm Global Small Cap Master Fund LP

    Vehicle through which additional shares were bought.

Related articles

$LMBMed

JPMorgan downgrades Limbach stock rating on valuation concerns

JPMorgan downgraded Limbach Holdings (LMB) to Underweight, lowering its price target to $50 from $60. The stock is near its 52-week low at $42.75. Five analysts revised earnings downward. The company reported Q2 2026 earnings and revenue below expectations, with near-term margin pressures cited. Stifel lowered its price target to $86 but maintained a Buy rating.

$LMBMedAI 8/10

Why Limbach Is Buying CYMCOR For $30 Million

Limbach Holdings said it acquired CYMCOR for about $30 million to expand in data center infrastructure services. The deal, funded via cash and borrowings under its revolving credit facility, is expected to add about $12 million of professional services revenue and $4 million of adjusted EBITDA in 2027. CYMCOR manages projects with over $8 billion in budgets.

$LMBMedAI 8/10

Read Analyst Questions From Limbach’s Q2 Earnings Call

Limbach (LMB) reported Q2 revenue of $173.5M, below analysts’ $177.3M estimate, and adjusted EPS of $0.64 versus $0.93 expected. Adjusted EBITDA was $13.94M versus $19.6M expected, with operating margin at 4.3%. CEO Michael McCann cited project timing and softer healthcare and institutional demand. Full-year revenue guidance was raised to $775M midpoint, but EBITDA guidance was below estimates.

$LMBMedAI 8/10

Limbach Q2 Earnings Call Highlights

Limbach Holdings (NASDAQ: LMB) reported Q2 revenue up 35.3% to $45 million, with organic GCR revenue up 12% and acquisition-related revenue up 23.3%. Gross margin fell to 21.5% from 28%, and net income dropped 38.8% to $4.7 million. Operating cash flow rose to $18.7 million. The company raised 2026 revenue guidance to $760M-$790M and lowered adjusted EBITDA to $78M-$84M.

$LMBHighAI 9/10

Why Limbach (LMB) Stock Is Nosediving

Limbach (LMB) shares fell 31.5% after the company reported mixed Q2 2026 results and guidance below expectations. Revenue was $173.5M vs $177.3M consensus. Adjusted EPS was $0.64, 30.9% below forecasts. Full-year revenue guidance rose, but EBITDA guidance of $81M missed Wall Street.